Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions(291 views visite) Maurea S, Imbriaco M, D'Angelillo M, Mollica C, Camera L, Salvatore M
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2006 Sep; 111(5): 674-686.
Dipartimento di Scienze Biomorfologiche e Funzionali (DSBMF), Università degli Studi di Napoli Federico II (UNINA), Consiglio Nazionale Delle Ricerche (CNR), Napoli, Italy Via Raffaele De Cesare 7, I-80132 Napoli, Italy
References Riferimenti: Mayo-Smith, W.W., Boland, G.W., Noto, R.B., Lee, M., State-of-the-art of adrenal imaging (2001) Radiographics, 21, pp. 995-101
Slapa, R.Z., Jakubowski, W., Januszewics, A., Discriminatory power of MRI for differentiation of adrenal non-adenomas vs adenomas evaluated by means of ROC analysis: Can biopsy be obviated? (2000) Eur Radiol, 10, pp. 95-104
Heinz-Peer, G., Honigschnabl, S., Schneider, B., Characterization of adrenal masses using MR imaging with histopatologic correlation (1999) AJR Am J Roentgenol, 173, pp. 15-22
Maurea, S., Cuocolo, A., Reynolds, J.C., Ruolo della risonanza magnetica nello studio dei feocromocitomi benigni e maligni: Analisi quantitativa dell'intensità del segnale di risonanza (1993) Radiol Med, 85, pp. 803-808
Maurea, S., Caracò, C., Castelli, L., La risonanza magnetica nello studio delle lesioni surrenaliche: Analisi qualitativa e quantitativa dell'intensità di segnale (1998) Radiol Med, 95, pp. 199-207
Semelka, R.C., Shoenut, J.P., Lawrence, P.H., Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging (1993) J Magn Reson Imaging, 3, pp. 337-343
Bilbey, J.H., Mc Loughlin, R.F., Kurkjian, P.S., MR imaging of adrenal masses: Value of chemical shift imaging for distinguishing adenoma from other tumors (1995) AJR Am J Roentgenol, 164, pp. 637-642
Hood, M.N., Ho, V.B., Smirniotopoulos, J.G., Chemical shift: The artifact and clinical tool revisited (1999) Radiographics, 19, pp. 357-371
Maurea, S., Klain, M., Mainolfi, C., The diagnostic role of radionuclide imaging in the evaluation of patients with non-hypersecreting adrenal masses (2001) J Nucl Med, 42, pp. 884-892
Yankaskas, B.C., Staab, E.V., Cravem, M.B., Delayed complications from fine-needle biopsies of solid masses of the abdomen (1986) Invest Radiol, 21, pp. 325-328
Gabriel, H., Pizzitola, V., McComb, E.N., Adrenal lesion with heterogeneous suppression on chemical shift imaging: Clinical implications (2004) J Magn Reson Imaging, 19, pp. 308-316
Shinozaki, K., Yoshimitsu, K., Honda, H., Metastatic adrenal tumor from clear-cell renal cell carcinoma: A pitfall of chemical-shift MR imaging (2001) Abdominal Imaging, 26, pp. 439-442
Honigschnabl, S., Gallo, S., Niederle, B., How accurate is MR imaging in characterization of adrenal masses: Update of a long-term study (2002) Eur J Radiol, 41, pp. 113-122
Namimoto, T., Yamashita, Y., Mitsuzaki, K., Adrenal masses: Quantification of fat content with double-echo chemical-shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas (2001) Radiology, 221, pp. 274-275
Fujiyoshi, F., Nakajo, M., Fukukura, Y., Tsuchimochi, S., Characterization of adrenal tumors by chemical-shift fast low-angle shot MR imaging: Comparison of four methods of quantitative evaluation (2003) AJR Am J Roentgenol, 180, pp. 1649-1657
Heider, M.A., Shai, S., Jhaveri, K., Lockwood, G., Chemical Shift MR imaging of hyperattenuating (>10 HU) adrenal masses: Does it still have a role? (2004) Radiology, 231, pp. 711-716
Mayo-Smith, W. W., Boland, G. W., Noto, R. B., Lee, M., State-of-the-art of adrenal imaging (2001) Radiographics, 21, pp. 995-101
Slapa, R. Z., Jakubowski, W., Januszewics, A., Discriminatory power of MRI for differentiation of adrenal non-adenomas vs adenomas evaluated by means of ROC analysis: Can biopsy be obviated? (2000) Eur Radiol, 10, pp. 95-104
Maurea, S., Carac, C., Castelli, L., La risonanza magnetica nello studio delle lesioni surrenaliche: Analisi qualitativa e quantitativa dell'Intensit di segnale (1998) Radiol Med, 95, pp. 199-207
Semelka, R. C., Shoenut, J. P., Lawrence, P. H., Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging (1993) J Magn Reson Imaging, 3, pp. 337-343
Bilbey, J. H., Mc Loughlin, R. F., Kurkjian, P. S., MR imaging of adrenal masses: Value of chemical shift imaging for distinguishing adenoma from other tumors (1995) AJR Am J Roentgenol, 164, pp. 637-642
Hood, M. N., Ho, V. B., Smirniotopoulos, J. G., Chemical shift: The artifact and clinical tool revisited (1999) Radiographics, 19, pp. 357-371
Gross, M. D., Shapiro, B., Clinical review 50. Clinically silent adrenal masses (1993) J Clin Endocr Metabol, 77, pp. 885-888
Yankaskas, B. C., Staab, E. V., Cravem, M. B., Delayed complications from fine-needle biopsies of solid masses of the abdomen (1986) Invest Radiol, 21, pp. 325-328
Heider, M. A., Shai, S., Jhaveri, K., Lockwood, G., Chemical Shift MR imaging of hyperattenuating (>10 HU) adrenal masses: Does it still have a role? (2004) Radiology, 231, pp. 711-716
Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions
Purpose. The objective of this study was to evaluate the diagnostic accuracy of chemical-shift (CS) magnetic resonance (MR) imaging in the differential diagnosis of adenoma and non adenoma adrenal masses. Materials and methods. We enrolled 36 patients (9 men, 27 women, mean age 51.3+14.4 years) with unilateral (n=31) or bilateral (n=5) adrenal masses incidentally discovered during imaging examinations [ultrasound (US), computed tomography (CT)] performed for other indications. A total of 41 adrenal lesions were evaluated (mean diameter 3.0+2.2 cm). Histology (n=19), biopsy (n=3) or clinical-imaging follow-up (n=19) demonstrated 29 adenomas, five pheochromocytomas, three cysts and four carcinomas. MR imaging was performed using the following breath-hold sequences: T1-fast field echo (FFE) [repetition time (TR)/echo time (TE)=236/4.6 ms], T2-turbo spin echo-single shot (TSE-SSh) (TR/TE=831/80 ms), T1-DUAL-FFE (TR=236, double TE=4.6/2.3 ms in phase and out of phase) and T1-FFE after gadolinium-DTPA (Gd). Axial and coronal imaging planes were used, with a slice thickness of 3-5 mm. MR images were qualitatively assessed for signal intensity of the adrenal mass relative to the liver on T1, T2, CS and T1-Gd scans; diagnostic criteria for adenomas were isointensity or hypointensity on both T1 and T2 scans, out-of-phase CS signal loss and mild transient enhancement after Gd. Results. Analysis of T1-T2 signal intensity showed diagnostic accuracy, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 80%, 72%, 100%, 100% and 60%, respectively. In contrast, analysis of CS and T1-Gd signal intensity showed diagnostic accuracy, sensitivity, specificity, PPV and NPV for both sequences of 93%, 90% (p
Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(406 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(224 visite) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 DettagliEsporta in BibTeXEsporta in EndNote
Ntziachristos V, Cuénod CA, Fournier L, Balvay D, Pradel C, Siauve N, Clement O, Jouannot E, Lucidarme O, Vecchio SD, Salvatore M, Law B, Tung C-H, Jain RK, Fukumura D, Munn LL, Brown EB, Schellenberger E, Montet X, Weissleder R, Clerck ND, Postnov A * Tumor Imaging(293 visite) Textbook Of In Vivo Imaging In Vertebrates (ISSN: 9780-4700), 2007 Jul 16; 1: 277-309. Impact Factor:1.148 DettagliEsporta in BibTeXEsporta in EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(544 visite) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 DettagliEsporta in BibTeXEsporta in EndNote
676 Records (644 escludendo Abstract e Conferenze). Impact factor totale: 2270.312 (2202.787 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 2389.249 (2315.257 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:15:06 291 views visite. Last view on Ultima visita in data Friday 22 January 2021, 13:07:49